Prediction of extracapsular extension of prostate cancer based on systematic core biopsies

References

• Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7–33
   PubMed Web of Science ®Google Scholar
• Stamey TA, Donaldson AN, Yemoto CE, McNeal JE, Sozen S, Gill H. Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. J Urol 1998; 160: 2412–7
   PubMed Web of Science ®Google Scholar
• Bahn DK, Lee F. Cryosurgical ablation therapy for prostate cancer. Arch Ital Urol Androl 2000; 72: 302–4
   PubMedGoogle Scholar
• Kiel HJ, Wieland WF, Rossler W. Local control of prostate cancer by transrectal HIFU-therapy. Arch Ital Urol Androl 2000; 72: 313–9
   PubMedGoogle Scholar
• Gancarczky KJ, Wu H, McLeod DG, Kane C, Kusuda L, Lance R, et al. Using the percentage of biopsy cores positive for cancer, pre-treatment PSA and highest biopsy Gleason sum to predict pathology stage after radical prostatectomy: The Center for Prostate Disease Research nomograms. Urology 2003; 61: 589–95
   PubMed Web of Science ®Google Scholar
• King CR, Patel DA, Terris MK. Prostate biopsy volume indices do not predict for significant Gleason upgrading. Am J Clin Oncol 2005; 28: 125–9
   PubMed Web of Science ®Google Scholar
• Ohori M, Wheeler TM, Kattan MW, Goto Y, Scardino PT. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 1995; 154: 1818–24
   PubMed Web of Science ®Google Scholar
• Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997; 277: 1445–51
   PubMed Web of Science ®Google Scholar
• Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol 2001; 163: 174–8
   Web of Science ®Google Scholar
• Cheng L, Slezak J, Bregstrall EJ, Myers RP, Zincke H, Bostwick DG. Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy. J Clin Oncol 2000; 18: 2862–8
   PubMed Web of Science ®Google Scholar
• Bostwick DG, Qian J, Bergstrall EJ, Dundore P, Dugan J, Myers RP, et al. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol 1996; 155: 1361–7
   PubMed Web of Science ®Google Scholar
• Stamey TA, McNeal JE, Freiha FS, Redwine E. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 1988; 139: 1235–41
   PubMed Web of Science ®Google Scholar
• Lorentzen T, Nerstrom H, Iversen P, Torp-Pedersen ST. Local staging of prostate cancer with transrectal ultrasound: a literature review. Prostate Suppl 1992; 4: 11–6
   PubMedGoogle Scholar
• Paulson DF, Moul JW, Walther PJ. Radical prostatectomy for clinical stage T1-T2N0M0 prostatic adenocarcinoma: long-term results. J Urol 1990; 144: 1180–4
   PubMed Web of Science ®Google Scholar
• Paulson DF. Impact of radical prostatectomy in management of clinically localized disease. J Urol 1994; 152: 1826–30
   PubMed Web of Science ®Google Scholar
• Grossfeld GD, Chang JJ, Boering JM, Li YP, Lubeck DP, Flanders SC, et al. Understaging and undergrading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol 2001; 165: 851–6
   PubMed Web of Science ®Google Scholar
• Lee AK, Schultz D, Renshaw AA, Richie JP, D'Amico AV. Patient selection for prostate monotherapy. Int J Radiat Oncol Phys 2001; 49: 673–7
   PubMed Web of Science ®Google Scholar
• Ogawa O, Egawa S, Arai Y, Tolisu K, Yoshida O, Kato T. Preoperative predictors for organ confined disease in Japanese patients with stage T1c prostate cancer. Int J Urol 1998; 5: 454–8
   PubMedGoogle Scholar
• Gohji K, Okamoto M, Takenaka A, Nomi M, Fujii A. Predicting the extent of prostate cancer using the combination of systematic biopsy and serum prostate specific antigen in Japanese men. BJU Int 1999; 83: 39–42
   PubMed Web of Science ®Google Scholar
• Peller PA, Young DC, Marmaduke DP, Marsh WL. Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy. Cancer 1995; 75: 530–8
   PubMed Web of Science ®Google Scholar
• Tigrani VS, Bhargava V, Sinohara K, Presti JC, Jr. Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy. Urology 1999; 54: 689–93
   PubMed Web of Science ®Google Scholar
• Amin M, Boccon-Gibod L, Egevad L, Epstein JI, Humphrey PA, Mikuz G, et al. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl 2005; 216: 20–33
   PubMedGoogle Scholar
• Ohori M, Kattan MW, Koh H, Maru N, Slawin KM, Shariat S, et al. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urol 2004; 171: 1844–9
   PubMed Web of Science ®Google Scholar
• Haese A, Epstein JI, Huland H, Partin AW. Validation of biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma. Cancer 2002; 95: 1016–21
   PubMed Web of Science ®Google Scholar
• Conrad S, Graefen M, Pichlmeier U, Henke RP, Mammerer PG, Huland H. Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma. J Urol 1998; 159: 2023–9
   PubMed Web of Science ®Google Scholar